Cardiovascular disease risk factors in chronic kidney disease - Overall burden and rates of treatment and control

被引:188
作者
Parikh, Nisha I.
Hwang, Shih-Jen
Larson, Martin G.
Meigs, James B.
Levy, Daniel
Fox, Caroline S.
机构
[1] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA
[2] Massachusetts Gen Hosp, Div Gen Med, Dept Med, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
[4] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA
[5] Harvard Univ, Sch Med, Dept Endocrinol Diabet & Hypertens, Brigham & Womens Hosp, Boston, MA 02115 USA
[6] NHLBI, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1001/archinte.166.17.1884
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Mild to moderate chronic kidney disease (CKD) is associated with increased risk for cardiovascular disease. The burden of cardiovascular disease risk factors in this setting is not well described. Methods: We compared the age- and sex-adjusted prevalence of cardiovascular disease risk factors and their treatment and control among persons with and without CKD in 3258 Framingham offspring cohort members who attended the seventh examination cycle (1998-2001). Glomerular filtration rate (GFR) was estimated using the simplified Modification of Diet in Renal Disease Study equation. We defined CKD as a GFR of less than 59 mL/min per 1.73 m(2) in women and less than 64 mL/min per 1.73 m(2) in men. Results: Those with CKD were older, more likely to be obese (33.5% vs 29.3%; P=.02), and more likely to have low levels of high-density lipoprotein cholesterol (45.2% vs 29.4%; P <.001) and high triglyceride levels (39.9% vs 29.8%; P <.001). Those with CKD had a higher prevalence of hypertension (71.2% vs 42.7%; P <.001) and hypertension treatment (86.0% vs 72.5%; P <.001), but were less likely to achieve optimal blood pressure control ( 27.0% vs 45.5%; P <. 001). Participants with CKD had a higher prevalence of elevated low-density lipoprotein cholesterol levels (60.5% vs 44.7%; P=.06) and lipid-lowering therapy (57.1% vs 42.6%; P=.09), although this was not statistically significant. A greater proportion of individuals with CKD than those without had diabetes (23.5% vs 11.9%; P=.02) and were receiving diabetes treatment (63.6% vs 46.9%; P=.05), but were less likely to achieve a hemoglobin A(1c) level of less than 7% (43.8% vs 59.4%; P=.03). Conclusions: Chronic kidney disease is associated with a significant burden of cardiovascular disease risk factors in the community. The diagnosis of CKD should alert the practitioner to look for potentially modifiable cardiovascular risk factors.
引用
收藏
页码:1884 / 1891
页数:8
相关论文
共 54 条
[21]   Cardiovascular medication use after coronary bypass surgery in patients with renal dysfunction: A National Veterans Administration study [J].
Gibney, EM ;
Casebeer, AW ;
Schooley, LM ;
Cunningham, F ;
Grover, FL ;
Bell, MR ;
McDonald, GO ;
Shroyer, AL ;
Parikh, CR .
KIDNEY INTERNATIONAL, 2005, 68 (02) :826-832
[22]   Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J].
Go, AS ;
Chertow, GM ;
Fan, DJ ;
McCulloch, CE ;
Hsu, CY .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1296-1305
[23]  
Hosmer D. W., 1989, APPL LOGISTIC REGRES, DOI DOI 10.1097/00019514-200604000-00003
[24]   INVESTIGATION OF CORONARY HEART-DISEASE IN FAMILIES - FRAMINGHAM OFFSPRING STUDY [J].
KANNEL, WB ;
FEINLEIB, M ;
MCNAMARA, PM ;
GARRISON, RJ ;
CASTELLI, WP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1979, 110 (03) :281-290
[25]   Blood pressure and end-stage renal disease in men [J].
Klag, MJ ;
Whelton, PK ;
Randall, BL ;
Neaton, JD ;
Brancati, FL ;
Ford, CE ;
Shulman, NB ;
Stamler, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (01) :13-18
[26]   A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation [J].
Levey, AS ;
Bosch, JP ;
Lewis, JB ;
Greene, T ;
Rogers, N ;
Roth, D .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :461-+
[27]   Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE study [J].
Longenecker, JC ;
Coresh, J ;
Powe, NR ;
Levey, AS ;
Fink, NE ;
Martin, A ;
Klag, MJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07) :1918-1927
[28]   Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community [J].
Manjunath, G ;
Tighiouart, H ;
Ibrahim, H ;
MacLeod, B ;
Salem, DN ;
Griffith, JL ;
Coresh, J ;
Levey, AS ;
Sarnak, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (01) :47-55
[29]   EFFECTS OF HYPERTENSION AND DYSLIPIDEMIA ON THE DECLINE IN RENAL-FUNCTION [J].
MANTTARI, M ;
TIULA, E ;
ALIKOSKI, T ;
MANNINEN, V .
HYPERTENSION, 1995, 26 (04) :670-675
[30]   Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study [J].
Muntner, P ;
Coresh, J ;
Smith, JC ;
Eckfeldt, J ;
Klag, MJ .
KIDNEY INTERNATIONAL, 2000, 58 (01) :293-301